|
device
|
OBI_0000968 |
|
|
vaccination
|
VO_0000002 |
|
|
parallel group design
|
OBI_0500006 |
|
|
n-to-1 design
|
OBI_0500004 |
|
|
cross over design
|
OBI_0500003 |
|
|
repeated measure design
|
OBI_0500002 |
|
|
clinical trial start date
|
OPMI_0000296 |
|
|
investigator
|
OPMI_0000293 |
|
|
clinical investigator
|
OPMI_0000294 |
|
|
organismal quality
|
PATO_0001995 |
|
|
primary sponsor role
|
OPMI_0000398 |
|
|
secondary sponsor role
|
OPMI_0000399 |
|
|
clinical trial early phase 1
|
CTO_0000202 |
|
|
investigation
|
OBI_0000066 |
|
|
clinical trial primary purpose specification
|
CTO_0000200 |
|
|
objective specification
|
IAO_0000005 |
|
|
clinical trial phase 4
|
CTO_0000206 |
|
|
clinical trial phase 3
|
CTO_0000205 |
|
|
clinical trial phase 2
|
CTO_0000204 |
|
|
clinical trial phase 1
|
CTO_0000203 |
|
